1. Home
  2. NEXT vs HROW Comparison

NEXT vs HROW Comparison

Compare NEXT & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextDecade Corporation

NEXT

NextDecade Corporation

SELL

Current Price

$6.80

Market Cap

2.0B

Sector

Energy

ML Signal

SELL

HROW

Harrow Inc.

SELL

Current Price

$28.24

Market Cap

1.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NEXT
HROW
Founded
2010
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
NEXT
HROW
Price
$6.80
$28.24
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$8.70
★ $65.00
AVG Volume (30 Days)
★ 2.3M
598.2K
Earning Date
10-29-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 71.43
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$28.59
Revenue Next Year
N/A
$53.17
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$27.00
52 Week High
$9.24
$54.98

Technical Indicators

Market Signals
Indicator
NEXT
HROW
Relative Strength Index (RSI) 50.20 21.75
Support Level $6.14 N/A
Resistance Level $7.79 $42.40
Average True Range (ATR) 0.26 1.28
MACD 0.04 -0.08
Stochastic Oscillator 83.33 20.31

Price Performance

Historical Comparison
NEXT
HROW

About NEXT NextDecade Corporation

NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: